Study of an experimental tablet in healthy adults
Part of Immune system & allergy, Skin clinical trials.
This study tests a new tablet, HL40626S, in healthy volunteers to understand its safety and how the body processes it. If you are a healthy adult, you may be able to help researchers gather important information for future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You have a body mass index (BMI) between 18 and 32 and weigh at least 110 pounds (50 kg).
- You are in good general health, with no major medical conditions.
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use birth control if needed.
- You have not had a respiratory infection treated with antibiotics within the last 12 weeks.
- You have not used alcohol within 72 hours before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This early-phase study tests an experimental oral tablet (UA026) in people with moderate to severe plaque psoriasis. The purpose is to see how safe and effective the drug is, and how it works in the body.
This trial tests an oral medication called HS-10374 for people with mild to moderate plaque psoriasis who haven't gotten enough relief from topical treatments. The study will check if the drug is safe and effective at clearing psoriasis patches.
This study tests a single dose of a new medicine, HCXT-2001, in healthy adults to evaluate its safety and what the body does to it. It helps determine if the drug is safe for further testing.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.